|
C10ORF118 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63369318073592E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.67033054054855E-12 |
| Normal-vs-Stage2 |
1.48820000767103E-09 |
| Normal-vs-Stage3 |
9.54670009711833E-10 |
| Normal-vs-Stage4 |
1.55129999956927E-07 |
| Stage1-vs-Stage2 |
7.916200E-01 |
| Stage1-vs-Stage3 |
8.074200E-01 |
| Stage1-vs-Stage4 |
5.439200E-01 |
| Stage2-vs-Stage3 |
9.654000E-01 |
| Stage2-vs-Stage4 |
6.712200E-01 |
| Stage3-vs-Stage4 |
6.715000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.69242397873859E-12 |
| Normal-vs-AfricanAmerican |
1.34819932995356E-11 |
| Normal-vs-Asian |
5.82740000032445E-07 |
| Caucasian-vs-AfricanAmerican |
7.210600E-01 |
| Caucasian-vs-Asian |
2.649200E-01 |
| AfricanAmerican-vs-Asian |
1.720990E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
2.78989999991097E-08 |
| Male-vs-Female |
3.682900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.70474745431193E-12 |
| Normal-vs-Extreme_Weight |
1.62458935193399E-12 |
| Normal-vs-Obese |
1.74730008239976E-10 |
| Normal-vs-Extreme_Obese |
2.56440000001579E-06 |
| Normal_Weight-vs-Extreme_Weight |
8.331800E-01 |
| Normal_Weight-vs-Obese |
3.925800E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.220800E-01 |
| Extreme_Weight-vs-Obese |
9.315700E-03 |
| Extreme_Weight-vs-Extreme_Obese |
3.581000E-01 |
| Obese-vs-Extreme_Obese |
6.624600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.14689999994611E-06 |
| Normal-vs-Age(41-60Yrs) |
1.20989995799903E-10 |
| Normal-vs-Age(61-80Yrs) |
1.11022302462516E-15 |
| Normal-vs-Age(81-100Yrs) |
6.65710042646595E-10 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.499000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.096000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.450100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.013900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.302200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.495200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62536650805123E-12 |
| Normal-VS-Type2 PRCC |
9.99200722162641E-16 |
| Normal-VS-KIRP CIMP |
6.395000E-04 |
| Normal-VS-Unclassified PRCC |
1.171040E-04 |
| Type1 PRCC-VS-Type2 PRCC |
4.293800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.633990E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.548200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
6.524100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.498500E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
9.811000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.52020626589911E-14 |
| Normal-vs-N1 |
6.05150000110299E-08 |
| Normal-vs-N2 |
4.642300E-04 |
| N0-vs-N1 |
1.680430E-01 |
| N0-vs-N2 |
8.478600E-01 |
| N1-vs-N2 |
4.448800E-01 |
|
|
